Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LY355703

Obstetrics and Gynecology

Volumn 95, Issue 6, 2000, Pages 1030-

  De Pas, Tommaso M ^a   Mandalè, Mario ^a   Curigliano, Giuseppe ^a   Peccatori, Fedro ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CRYPTOPHYCIN 52; DOXORUBICIN; IFOSFAMIDE;

ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; LIVER METASTASIS; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; STOMACH CANCER; VULVAR VESTIBULITIS;

ACUTE DISEASE; ANTIBIOTICS, ANTINEOPLASTIC; DEPSIPEPTIDES; FEMALE; HUMANS; LACTAMS; LACTONES; MIDDLE AGED; NEUROTOXICITY SYNDROMES; VULVITIS;

EID: 0343729392     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00833-4     Document Type: Article

References (4)

1. Paavonen J. Diagnosis and treatment of vulvodynia. Ann Med 1995;27:175-81.
2. Smith CD, Zhang X, Mooberry SL, Patterson GM, Moore RE. Cryptophycin: A new antimicrotubule agent active against drug-resistant cells. Cancer Res 1994;54:3779-84.
3. Bergeron S, Binik YM, Khalifè S, Pagidas K. Vulvar vestibulitis syndrome: A critical review. Clin J Pain 1997;13:27-42.
4. Marinoff SC, Turner MLC. Vulvar vestibulitis syndrome. An overview. Am J Obstet Gynecol 1991;165:1228-33.